n-n-propyl-n-n-butyl-beta-dopamine has been researched along with domperidone in 3 studies
| Studies (n-n-propyl-n-n-butyl-beta-dopamine) | Trials (n-n-propyl-n-n-butyl-beta-dopamine) | Recent Studies (post-2010) (n-n-propyl-n-n-butyl-beta-dopamine) | Studies (domperidone) | Trials (domperidone) | Recent Studies (post-2010) (domperidone) |
|---|---|---|---|---|---|
| 17 | 1 | 0 | 1,977 | 275 | 468 |
| Protein | Taxonomy | n-n-propyl-n-n-butyl-beta-dopamine (IC50) | domperidone (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 7.9 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.332 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.614 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.74 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0026 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 2.125 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.011 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.614 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.065 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.037 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.332 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.055 | |
| Histamine H1 receptor | Homo sapiens (human) | 1.344 | |
| Mu-type opioid receptor | Homo sapiens (human) | 4.218 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.018 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 6.994 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 2.6 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0052 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1447 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 2.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, FL; Fennell, WH; Zhao, RR | 1 |
| Jin, XH; Wang, WZ; Zhao, RR; Zhu, L | 1 |
| Dun, W; Li, JG; Wu, BW; Zhao, RR | 1 |
3 other study(ies) available for n-n-propyl-n-n-butyl-beta-dopamine and domperidone
| Article | Year |
|---|---|
Effects of dopamine D1 and dopamine D2 receptor agonists on coronary and peripheral hemodynamics.
Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Circulation; Dogs; Domperidone; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Heart; In Vitro Techniques; Male; Receptors, Dopamine; Regional Blood Flow; Vascular Resistance | 1990 |
Effects of long-term application of dopamine HCl on dopamine agonist-induced cAMP production in rat renal cortex.
Topics: Animals; Benzazepines; Cyclic AMP; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Fenoldopam; Kidney Cortex; Male; Rats; Rats, Wistar | 1998 |
Inhibition of myocardial inward rectifier potassium current by propylbutyldopamine.
Topics: Action Potentials; Animals; Calcium Channels; Cell Separation; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Guinea Pigs; Myocardium; Patch-Clamp Techniques; Potassium Channels | 1999 |